Scrotal Cellulitis Antibiotic Selection
Scrotal cellulitis should be treated as nonpurulent skin cellulitis unless abscess or purulent drainage is present. Empiric antibiotic selection should target streptococci for typical cases without systemic signs and should expand to MRSA coverage for severe cases or specific MRSA risk features. [1]
Infection Phenotype Stratification
- Mild nonpurulent cellulitis (typical diffuse cellulitis without systemic signs of infection) should receive an antimicrobial active against streptococci. [1]
- Moderate nonpurulent cellulitis (cellulitis with systemic signs of infection) should receive systemic antibiotics. [1]
- Severe nonpurulent cellulitis (cellulitis associated with penetrating trauma, evidence of MRSA infection elsewhere, nasal colonization with MRSA, injection drug use, or SIRS features) should receive vancomycin or another agent active against both MRSA and streptococci. [1]
Streptococcal Cellulitis Empiric Antibiotic Options (Mild)
Antibiotics active against streptococci are recommended for typical mild nonpurulent cellulitis. [1]
Common options (adult regimens in the IDSA guideline table) include: [1]
- Penicillin (2–4 million units IV every 4–6 hours). [1]
- Clindamycin (600–900 mg IV every 8 hours). [1]
- Nafcillin (1–2 g IV every 4–6 hours). [1]
- Cefazolin (1 g IV every 8 hours). [1]
- Penicillin VK (250–500 mg by mouth every 6 hours). [1]
- Cephalexin (500 mg by mouth every 6 hours). [1]
MRSA-Active Empiric Antibiotic Options (Severe Nonpurulent)
When severe nonpurulent cellulitis features are present, vancomycin or another agent active against both MRSA and streptococci is recommended. [1]
Empiric regimens for severe infections include: [1]
- Vancomycin plus piperacillin-tazobactam. [1]
- Vancomycin plus imipenem/meropenem. [1]
Treatment Initiation Thresholds and Monitoring
- Outpatient therapy is recommended for patients without SIRS, altered mental status, or hemodynamic instability (mild nonpurulent). [1]
- Hospitalization is recommended if concern exists for deeper or necrotizing infection, for poor adherence to therapy, for severe immunocompromise, or if outpatient treatment is failing (moderate or severe nonpurulent). [1]
- Cultures and blood cultures are not needed for typical cases of cellulitis, but cultures and microscopic examination should be considered in specific immunocompromised or bite/immersion contexts. [1]
Duration of Therapy
The recommended duration of antimicrobial therapy is 5 days. Treatment should be extended if the infection has not improved within this time period. [1]
Key Clinical Nuances for Genital-Region Cellulitis
- Cellulitis antibiotic therapy selection depends on purulence and systemic severity. [1]
- Predisposing factors should be treated during the acute stage, and elevation of the affected area is recommended. [1]
Common Pitfalls to Avoid
- Treating purulent skin collections (e.g., abscess or furuncle) as simple cellulitis without source control is a classification error that should prompt evaluation for drainage. [1]
- Failure to broaden therapy when severe nonpurulent features (including MRSA risk features or SIRS) are present is inconsistent with IDSA recommendations. [1]
Target Goals of Therapy
- Clinical improvement should occur within the initial 5-day treatment window. [1]
- Therapy should be extended when improvement has not occurred by day 5. [1]